<!DOCTYPE html>
<html>
  <head>
	  <title>MedStudyBuddy | Title</title>
		<!--[if lt IE 9]>
			<script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script>
		<![endif]-->
		<link href="/stylesheets/blueprint/screen.css" media="screen" rel="stylesheet" type="text/css" />
		<link href="/stylesheets/blueprint/print.css" media="print" rel="stylesheet" type="text/css" />
		<!--[if lt IE8]>
			<link href="/stylesheets/blueprint/ie.css" media="screen" rel="stylesheet" type="text/css" />
		<![endif]-->
		<link href="/stylesheets/notes.css" media="screen" rel="stylesheet" type="text/css" />
		<link href="/stylesheets/sticky-footer.css" media="screen" rel="stylesheet" type="text/css" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="shortcut icon" href="/images/favicon.ico" />
		<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:24.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Cambria","serif";
	color:#365F91;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Cambria","serif";
	color:#4F81BD;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-link:"Subtitle Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	color:#4F81BD;
	letter-spacing:.75pt;
	font-style:italic;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
span.MsoSubtleEmphasis
	{color:gray;
	font-style:italic;}
span.MsoIntenseEmphasis
	{color:#4F81BD;
	font-weight:bold;
	font-style:italic;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Cambria","serif";
	color:#365F91;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Cambria","serif";
	color:#4F81BD;
	font-weight:bold;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-link:Subtitle;
	font-family:"Cambria","serif";
	color:#4F81BD;
	letter-spacing:.75pt;
	font-style:italic;}
p.MSBHeading1, li.MSBHeading1, div.MSBHeading1
	{mso-style-name:"MSB Heading 1";
	mso-style-link:"MSB Heading 1 Char";
	margin:0cm;
	margin-bottom:.0001pt;
	line-height:150%;
	font-size:18.0pt;
	font-family:"Candara","sans-serif";
	color:purple;
	font-weight:bold;}
p.MSBHeading2, li.MSBHeading2, div.MSBHeading2
	{mso-style-name:"MSB Heading 2";
	mso-style-link:"MSB Heading 2 Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:16.0pt;
	font-family:"Calibri","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.MSBHeading1Char
	{mso-style-name:"MSB Heading 1 Char";
	mso-style-link:"MSB Heading 1";
	font-family:"Candara","sans-serif";
	color:purple;
	font-weight:bold;}
p.MSBsub-heading, li.MSBsub-heading, div.MSBsub-heading
	{mso-style-name:"MSB sub-heading";
	mso-style-link:"MSB sub-heading Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:14.0pt;
	font-family:"Candara","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.MSBHeading2Char
	{mso-style-name:"MSB Heading 2 Char";
	mso-style-link:"MSB Heading 2";
	font-family:"Calibri","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBnormaltext, li.MSBnormaltext, div.MSBnormaltext
	{mso-style-name:"MSB normal text";
	mso-style-link:"MSB normal text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MSBnormaltextCxSpFirst, li.MSBnormaltextCxSpFirst, div.MSBnormaltextCxSpFirst
	{mso-style-name:"MSB normal textCxSpFirst";
	mso-style-link:"MSB normal text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MSBnormaltextCxSpMiddle, li.MSBnormaltextCxSpMiddle, div.MSBnormaltextCxSpMiddle
	{mso-style-name:"MSB normal textCxSpMiddle";
	mso-style-link:"MSB normal text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MSBnormaltextCxSpLast, li.MSBnormaltextCxSpLast, div.MSBnormaltextCxSpLast
	{mso-style-name:"MSB normal textCxSpLast";
	mso-style-link:"MSB normal text Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
span.MSBsub-headingChar
	{mso-style-name:"MSB sub-heading Char";
	mso-style-link:"MSB sub-heading";
	font-family:"Candara","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.MSBnormaltextChar
	{mso-style-name:"MSB normal text Char";
	mso-style-link:"MSB normal text";
	font-family:"Arial","sans-serif";}
p.MSBsub-headingitalics, li.MSBsub-headingitalics, div.MSBsub-headingitalics
	{mso-style-name:"MSB sub-heading \(italics\)";
	mso-style-link:"MSB sub-heading \(italics\) Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:14.0pt;
	font-family:"Candara","sans-serif";
	font-weight:bold;
	font-style:italic;
	text-decoration:underline;}
span.MSBsub-headingitalicsChar
	{mso-style-name:"MSB sub-heading \(italics\) Char";
	mso-style-link:"MSB sub-heading \(italics\)";
	font-family:"Candara","sans-serif";
	font-weight:bold;
	font-style:italic;
	text-decoration:underline;}
p.MSBitalicsnormaltext, li.MSBitalicsnormaltext, div.MSBitalicsnormaltext
	{mso-style-name:"MSB italics normal text";
	mso-style-link:"MSB italics normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.MSBitalicsnormaltextCxSpFirst, li.MSBitalicsnormaltextCxSpFirst, div.MSBitalicsnormaltextCxSpFirst
	{mso-style-name:"MSB italics normal textCxSpFirst";
	mso-style-link:"MSB italics normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.MSBitalicsnormaltextCxSpMiddle, li.MSBitalicsnormaltextCxSpMiddle, div.MSBitalicsnormaltextCxSpMiddle
	{mso-style-name:"MSB italics normal textCxSpMiddle";
	mso-style-link:"MSB italics normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.MSBitalicsnormaltextCxSpLast, li.MSBitalicsnormaltextCxSpLast, div.MSBitalicsnormaltextCxSpLast
	{mso-style-name:"MSB italics normal textCxSpLast";
	mso-style-link:"MSB italics normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.MSBReference, li.MSBReference, div.MSBReference
	{mso-style-name:"MSB Reference";
	mso-style-link:"MSB Reference Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MSBReferenceCxSpFirst, li.MSBReferenceCxSpFirst, div.MSBReferenceCxSpFirst
	{mso-style-name:"MSB ReferenceCxSpFirst";
	mso-style-link:"MSB Reference Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MSBReferenceCxSpMiddle, li.MSBReferenceCxSpMiddle, div.MSBReferenceCxSpMiddle
	{mso-style-name:"MSB ReferenceCxSpMiddle";
	mso-style-link:"MSB Reference Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
p.MSBReferenceCxSpLast, li.MSBReferenceCxSpLast, div.MSBReferenceCxSpLast
	{mso-style-name:"MSB ReferenceCxSpLast";
	mso-style-link:"MSB Reference Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:20.95pt;
	margin-bottom:.0001pt;
	text-indent:-17.85pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";}
span.MSBitalicsnormaltextChar
	{mso-style-name:"MSB italics normal text Char";
	mso-style-link:"MSB italics normal text";
	font-family:"Arial","sans-serif";
	font-style:italic;}
span.MSBReferenceChar
	{mso-style-name:"MSB Reference Char";
	mso-style-link:"MSB Reference";
	font-family:"Arial","sans-serif";}
p.MSBreferenceHeading, li.MSBreferenceHeading, div.MSBreferenceHeading
	{mso-style-name:"MSB reference Heading";
	mso-style-link:"MSB reference Heading Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
span.MSBreferenceHeadingChar
	{mso-style-name:"MSB reference Heading Char";
	mso-style-link:"MSB reference Heading";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBunderlinearrowbullet, li.MSBunderlinearrowbullet, div.MSBunderlinearrowbullet
	{mso-style-name:"MSB underline + arrow bullet";
	mso-style-link:"MSB underline + arrow bullet Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
p.MSBunderlinearrowbulletCxSpFirst, li.MSBunderlinearrowbulletCxSpFirst, div.MSBunderlinearrowbulletCxSpFirst
	{mso-style-name:"MSB underline + arrow bulletCxSpFirst";
	mso-style-link:"MSB underline + arrow bullet Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
p.MSBunderlinearrowbulletCxSpMiddle, li.MSBunderlinearrowbulletCxSpMiddle, div.MSBunderlinearrowbulletCxSpMiddle
	{mso-style-name:"MSB underline + arrow bulletCxSpMiddle";
	mso-style-link:"MSB underline + arrow bullet Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
p.MSBunderlinearrowbulletCxSpLast, li.MSBunderlinearrowbulletCxSpLast, div.MSBunderlinearrowbulletCxSpLast
	{mso-style-name:"MSB underline + arrow bulletCxSpLast";
	mso-style-link:"MSB underline + arrow bullet Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	text-indent:-18.0pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
span.MSBunderlinearrowbulletChar
	{mso-style-name:"MSB underline + arrow bullet Char";
	mso-style-link:"MSB underline + arrow bullet";
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Tahoma","sans-serif";}
p.MSBnormaltextnolist, li.MSBnormaltextnolist, div.MSBnormaltextnolist
	{mso-style-name:"MSB normal text \(no list\)";
	mso-style-link:"MSB normal text \(no list\) Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MSBnormaltextnolistCxSpFirst, li.MSBnormaltextnolistCxSpFirst, div.MSBnormaltextnolistCxSpFirst
	{mso-style-name:"MSB normal text \(no list\)CxSpFirst";
	mso-style-link:"MSB normal text \(no list\) Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MSBnormaltextnolistCxSpMiddle, li.MSBnormaltextnolistCxSpMiddle, div.MSBnormaltextnolistCxSpMiddle
	{mso-style-name:"MSB normal text \(no list\)CxSpMiddle";
	mso-style-link:"MSB normal text \(no list\) Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MSBnormaltextnolistCxSpLast, li.MSBnormaltextnolistCxSpLast, div.MSBnormaltextnolistCxSpLast
	{mso-style-name:"MSB normal text \(no list\)CxSpLast";
	mso-style-link:"MSB normal text \(no list\) Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";}
p.MSBboldnormaltext, li.MSBboldnormaltext, div.MSBboldnormaltext
	{mso-style-name:"MSB bold normal text";
	mso-style-link:"MSB bold normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
p.MSBboldnormaltextCxSpFirst, li.MSBboldnormaltextCxSpFirst, div.MSBboldnormaltextCxSpFirst
	{mso-style-name:"MSB bold normal textCxSpFirst";
	mso-style-link:"MSB bold normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
p.MSBboldnormaltextCxSpMiddle, li.MSBboldnormaltextCxSpMiddle, div.MSBboldnormaltextCxSpMiddle
	{mso-style-name:"MSB bold normal textCxSpMiddle";
	mso-style-link:"MSB bold normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
p.MSBboldnormaltextCxSpLast, li.MSBboldnormaltextCxSpLast, div.MSBboldnormaltextCxSpLast
	{mso-style-name:"MSB bold normal textCxSpLast";
	mso-style-link:"MSB bold normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
span.MSBnormaltextnolistChar
	{mso-style-name:"MSB normal text \(no list\) Char";
	mso-style-link:"MSB normal text \(no list\)";
	font-family:"Arial","sans-serif";}
p.MSBunderlinenormaltext, li.MSBunderlinenormaltext, div.MSBunderlinenormaltext
	{mso-style-name:"MSB underline normal text";
	mso-style-link:"MSB underline normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
p.MSBunderlinenormaltextCxSpFirst, li.MSBunderlinenormaltextCxSpFirst, div.MSBunderlinenormaltextCxSpFirst
	{mso-style-name:"MSB underline normal textCxSpFirst";
	mso-style-link:"MSB underline normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
p.MSBunderlinenormaltextCxSpMiddle, li.MSBunderlinenormaltextCxSpMiddle, div.MSBunderlinenormaltextCxSpMiddle
	{mso-style-name:"MSB underline normal textCxSpMiddle";
	mso-style-link:"MSB underline normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
p.MSBunderlinenormaltextCxSpLast, li.MSBunderlinenormaltextCxSpLast, div.MSBunderlinenormaltextCxSpLast
	{mso-style-name:"MSB underline normal textCxSpLast";
	mso-style-link:"MSB underline normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
span.MSBboldnormaltextChar
	{mso-style-name:"MSB bold normal text Char";
	mso-style-link:"MSB bold normal text";
	font-family:"Arial","sans-serif";
	font-weight:bold;}
p.MSBemphasis1x, li.MSBemphasis1x, div.MSBemphasis1x
	{mso-style-name:"MSB emphasis 1x";
	mso-style-link:"MSB emphasis 1x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBemphasis1xCxSpFirst, li.MSBemphasis1xCxSpFirst, div.MSBemphasis1xCxSpFirst
	{mso-style-name:"MSB emphasis 1xCxSpFirst";
	mso-style-link:"MSB emphasis 1x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBemphasis1xCxSpMiddle, li.MSBemphasis1xCxSpMiddle, div.MSBemphasis1xCxSpMiddle
	{mso-style-name:"MSB emphasis 1xCxSpMiddle";
	mso-style-link:"MSB emphasis 1x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBemphasis1xCxSpLast, li.MSBemphasis1xCxSpLast, div.MSBemphasis1xCxSpLast
	{mso-style-name:"MSB emphasis 1xCxSpLast";
	mso-style-link:"MSB emphasis 1x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.MSBunderlinenormaltextChar
	{mso-style-name:"MSB underline normal text Char";
	mso-style-link:"MSB underline normal text";
	font-family:"Arial","sans-serif";
	text-decoration:underline;}
p.MSBemphasis2x, li.MSBemphasis2x, div.MSBemphasis2x
	{mso-style-name:"MSB emphasis 2x";
	mso-style-link:"MSB emphasis 2x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	color:#CC66FF;
	font-weight:bold;
	font-style:italic;}
p.MSBemphasis2xCxSpFirst, li.MSBemphasis2xCxSpFirst, div.MSBemphasis2xCxSpFirst
	{mso-style-name:"MSB emphasis 2xCxSpFirst";
	mso-style-link:"MSB emphasis 2x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	color:#CC66FF;
	font-weight:bold;
	font-style:italic;}
p.MSBemphasis2xCxSpMiddle, li.MSBemphasis2xCxSpMiddle, div.MSBemphasis2xCxSpMiddle
	{mso-style-name:"MSB emphasis 2xCxSpMiddle";
	mso-style-link:"MSB emphasis 2x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	color:#CC66FF;
	font-weight:bold;
	font-style:italic;}
p.MSBemphasis2xCxSpLast, li.MSBemphasis2xCxSpLast, div.MSBemphasis2xCxSpLast
	{mso-style-name:"MSB emphasis 2xCxSpLast";
	mso-style-link:"MSB emphasis 2x Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	color:#CC66FF;
	font-weight:bold;
	font-style:italic;}
span.MSBemphasis1xChar
	{mso-style-name:"MSB emphasis 1x Char";
	mso-style-link:"MSB emphasis 1x";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.Referenceheading, li.Referenceheading, div.Referenceheading
	{mso-style-name:"Reference heading";
	mso-style-link:"Reference heading Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.MSBemphasis2xChar
	{mso-style-name:"MSB emphasis 2x Char";
	mso-style-link:"MSB emphasis 2x";
	font-family:"Arial","sans-serif";
	color:#CC66FF;
	font-weight:bold;
	font-style:italic;}
span.ReferenceheadingChar
	{mso-style-name:"Reference heading Char";
	mso-style-link:"Reference heading";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-link:"Style1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.Style1CxSpFirst, li.Style1CxSpFirst, div.Style1CxSpFirst
	{mso-style-name:Style1CxSpFirst;
	mso-style-link:"Style1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.Style1CxSpMiddle, li.Style1CxSpMiddle, div.Style1CxSpMiddle
	{mso-style-name:Style1CxSpMiddle;
	mso-style-link:"Style1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.Style1CxSpLast, li.Style1CxSpLast, div.Style1CxSpLast
	{mso-style-name:Style1CxSpLast;
	mso-style-link:"Style1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:3.1pt;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-style:italic;}
span.Style1Char
	{mso-style-name:"Style1 Char";
	mso-style-link:Style1;
	font-family:"Arial","sans-serif";
	font-style:italic;}
p.MSBboldunderlinednormaltext, li.MSBboldunderlinednormaltext, div.MSBboldunderlinednormaltext
	{mso-style-name:"MSB bold underlined normal text";
	mso-style-link:"MSB bold underlined normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBboldunderlinednormaltextCxSpFirst, li.MSBboldunderlinednormaltextCxSpFirst, div.MSBboldunderlinednormaltextCxSpFirst
	{mso-style-name:"MSB bold underlined normal textCxSpFirst";
	mso-style-link:"MSB bold underlined normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBboldunderlinednormaltextCxSpMiddle, li.MSBboldunderlinednormaltextCxSpMiddle, div.MSBboldunderlinednormaltextCxSpMiddle
	{mso-style-name:"MSB bold underlined normal textCxSpMiddle";
	mso-style-link:"MSB bold underlined normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
p.MSBboldunderlinednormaltextCxSpLast, li.MSBboldunderlinednormaltextCxSpLast, div.MSBboldunderlinednormaltextCxSpLast
	{mso-style-name:"MSB bold underlined normal textCxSpLast";
	mso-style-link:"MSB bold underlined normal text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
span.MSBboldunderlinednormaltextChar
	{mso-style-name:"MSB bold underlined normal text Char";
	mso-style-link:"MSB bold underlined normal text";
	font-family:"Arial","sans-serif";
	font-weight:bold;
	text-decoration:underline;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
  </head>
  <body>
	  <div id="wrap">
			<div id="main" class="container">
		  	<div id="header">
					<div style="float:left;">
						<img src="/images/MSBLogo.png">
					</div>
					<img src="/images/MSBText.png">
				</div>
				<div id="content" class="span-16 append-1 prepend-1">					
					<div class="WordSection1">

<p class="MSBHeading1">Hypertension</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Persistently raised BP &gt;140/90 </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Can be systolic, diastolic or both<i> (systolic most important)</i></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Measure twice on 2 separate occasions under best conditions possible</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Complications: CVD, Stroke, PVD, HF (LVH), RF, visual impairment
(retinopathy)</p>

<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" align="right" style="background:#CC99FF;border-collapse:collapse;border:none;margin-left:
 7.2pt;margin-right:7.2pt"><tr style="height:77.45pt">
<td valign="top" style="border:solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;
  height:77.45pt">
  <p class="MsoNormal"><u>Grades of Hypertension</u></p>
  <p class="MsoNormal"> </p>
  <ul style="margin-top:0cm" type="circle">
<li class="MsoNormal">Mild                 – 140-159/90-99</li>
   <li class="MsoNormal">Moderate         – 160-179/100-109</li>
   <li class="MsoNormal">Severe             –  &gt;180/110</li>
  </ul>
<p class="MsoNormal"> </p>
  </td>
 </tr></table>
<p class="MsoNormal" style="margin-left:21.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Predominately managed in primary care</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Screen BP every 3 years if &gt;50</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Refer if: ?secondary cause </p>

<p class="MsoNormal" style="margin-left:21.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt"> </p>

<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" style="background:#D9D9D9;border-collapse:collapse;border:none"><tr>
<td width="770" valign="top" style="width:462.1pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MSBHeading2">Measuring BP</p>
  <p class="MsoNormal"> </p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Quiet relaxed calm environment</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Patient seated &gt;5 minutes</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Can use either arm (if one higher than the other use higher value)</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Arm outstretched and supported at level of heart</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Cuff should be able to fit around the arm twice</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Estimate systolic BP by palpating for disappearance of brachial pulse
  while inflating the cuff</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Inflate cuff a further 30mmHg</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Deflate at 2mmHg /second</p>
  <p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
  </span></span>Systolic = Korotkoff I – appearance of sustained tapping</p>
  <p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
  </span></span>Diastolic = Korotkoff V – disappearance of sounds. However in
  some patients (eg pregnant women) sounds are present until 0 mmHg. In these
  patients Korotkoff IV (the muffling of sounds) should be used.</p>
  <p class="MsoNormal" style="margin-left:21.0pt"> </p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>If &gt;140/90, measure again at end of consultation</p>
  <p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
  </span></span>If still high, repeat in 1-3 months</p>
  <p class="MsoNormal" style="margin-left:21.0pt"> </p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>If ?postural hypotension – measure their BP while standing (for up to
  3 mins)</p>
  <p class="MsoNormal"> </p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Can only use machines is properly calibrated and validated as per
  manufacturer instructions</p>
  <p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
  </span>Routine use of ambulatory BP monitoring is not recommended in primary
  care</p>
  <p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
  </span></span>Consider if ?white coat hypertension or hypotension in response
  to treatment</p>
  <p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
  </span></span>Loss of nocturnal dip is a poor prognostic sign</p>
  <p class="MsoNormal"> </p>
  </td>
 </tr></table>
<p class="MsoNormal"> </p>

<p class="MSBHeading2">Threshold for offering Drug treatment:</p>

<p class="MsoNormal"> </p>

<p class="MsoNormal" style="margin-left:36.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">Ø<span style='font:7.0pt "Times New Roman"'> 
</span></span>Persistent BP &gt;160/100</p>

<p class="MsoNormal" style="margin-left:36.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">Ø<span style='font:7.0pt "Times New Roman"'> 
</span></span>Isolated systolic hypertension &gt;160</p>

<p class="MsoNormal" style="margin-left:36.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">Ø<span style='font:7.0pt "Times New Roman"'> 
</span></span>BP &gt;140/90 in patients with</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>10-year risk of CVD &gt; 20% </p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Signs of target organ damage (incl existing CVD) </p>

<p class="MsoNormal" style="margin-left:57.0pt"> </p>

<p class="MsoNormal">*CVD risk = risk of stroke and MI</p>

<p class="MsoNormal">Have lower threshold for treatment in patients with diabetes</p>

<p class="MsoNormal">Aim: to reduce BP &lt;140/90 (130/80 if diabetic)</p>

<p class="MsoNormal"><u><span style="text-decoration:none"> </span></u></p>

<p class="MSBemphasis1x"><u>Signs of end organ damage</u></p>

<p class="MsoNormal"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">v<span style='font:7.0pt "Times New Roman"'> 
</span></span>ECG – LVH (S wave in V2 + R wave V6 &gt;35mm)</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">v<span style='font:7.0pt "Times New Roman"'> 
</span></span>Kidneys proteinuria</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">v<span style='font:7.0pt "Times New Roman"'> 
</span></span>Retinopathy – fundoscopy</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">v<span style='font:7.0pt "Times New Roman"'> 
</span></span>PMH of CVD/MI</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">v<span style='font:7.0pt "Times New Roman"'> 
</span></span>PMH of stroke/TIA</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style="font-family:Wingdings">v<span style='font:7.0pt "Times New Roman"'> 
</span></span>PMH of PVD</p>

<p class="MsoNormal"> </p>

<p class="MSBemphasis1x"><u>Global CV risk</u></p>

<p class="MsoNormal"><u><span style="text-decoration:none"> </span></u></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Can be calculated using tables in the BNF</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Calculated using: Diabetes, age, male, smoker, systolic BP, total serum
cholesterol:HDL ratio.</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>View the tables at:<i> <a href="http://www.ncbi.nlm.nih.gov/books/NBK45860/figure/summary.fu1/?report=objectonly">http://www.ncbi.nlm.nih.gov/books/NBK45860/figure/summary.fu1/?report=objectonly</a>
</i></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>For more information see:</p>

<p class="MsoNormal"><i><a href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=nicecg18&amp;part=summary">http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=nicecg18&amp;part=summary</a></i></p>

<p class="MsoNormal"><i> </i></p>

<p class="MsoNormal"><i> </i></p>

<p class="MSBemphasis1x"><u>If hypertension without existing CV disease consider
formal assessment of CV risk</u></p>

<p class="MsoNormal"><u><span style="text-decoration:none"> </span></u></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Urine dipstick for protein</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Bloods: plasma glucose, U+Es, serum total cholesterol and HDL</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>ECG</p>

<p class="MsoNormal" style="margin-left:21.0pt"> </p>

<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" style="background:#CC99FF;border-collapse:collapse;border:none"><tr>
<td width="770" valign="top" style="width:462.1pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MsoNormal"><i>Case: </i></p>
  <p class="MsoNormal"><i> </i></p>
  <p class="MsoNormal"><i>52 year old male, non-smoker with persistent BP of
  145/95.</i></p>
  <p class="MsoNormal"><i> </i></p>
  <p class="MsoNormal" style="margin-left:32.2pt;text-indent:-18.0pt"><i>1)<span style='font:7.0pt "Times New Roman"'>     </span></i><i>Signs
  of end organ damage?</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>History</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>ECG</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>Dip
  urine</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>Fundoscopy</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt"><i> </i></p>
  <p class="MsoNormal" style="margin-left:32.2pt;text-indent:-18.0pt"><i>2)<span style='font:7.0pt "Times New Roman"'>     </span></i><i>Global
  CVD risk &gt;20%?</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>Measure
  glucose</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>Cholesterol</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>BP</i></p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><i>Smoking
  status</i></p>
  <p class="MsoNormal"><i> </i></p>
  <p class="MsoNormal"><i>If none present </i><i><span style="font-family:Wingdings">à</span></i><i>
  Lifestyle advice and monitor BP every 3 months.</i></p>
  <p class="MsoNormal"> </p>
  </td>
 </tr></table>
<p class="MsoNormal"> </p>

<p class="MSBHeading2">Management</p>

<p class="MsoNormal"> </p>

<p class="MsoNormal"><u>Lifestyle interventions</u></p>

<p class="MsoNormal"> </p>

<p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span>Diet,
weight loss, exercise, alcohol, reduce salt, smoking cessation.</p>

<p class="MsoNormal"> </p>

<p class="MsoNormal"><u>Pharmacological Management</u></p>

<p class="MsoNormal"> </p>

<p class="MSBemphasis1x"><u>ACD algorithm</u></p>

<p class="MsoNormal"> </p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
</span></span>If &lt; 55                               <span style="font-family:
Wingdings">à</span> ACEi (or A2RB)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
</span></span>If &gt; 55 (or black)               <span style="font-family:
Wingdings">à</span> CCB or Thiazide diuretic</p>

<p class="MsoNormal"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>If still not controlled, use either A+D or A+C </p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span><i>(i.e. dual therapy always involves an ace inhibitor/A2RB)</i></p>

<p class="MsoNormal"> </p>

<p class="MsoNormal">For a picture diagram od the ACD algorithm see: <i><span style="font-size:10.0pt">NICE clinical Guideline 34. 2006. Hypertension:
Management of Adults in Primary Care. <a href="http://www.nice.org.uk/CG034">http://www.nice.org.uk/CG034</a>
</span></i></p>

<p class="MsoNormal"> </p>

<p class="MSBemphasis1x"><u>General Notes:</u></p>

<p class="MsoNormal" style="margin-left:3.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Aim for BP &lt;140/90 (130/80 of diabetic)</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>*Reduce blood pressure slowly (can precipitate stroke if rapid)</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span><span lang="EN-US">Most drugs take <b>4-6 weeks</b> to have maximum
effect!!!</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span><span lang="EN-US">Address global CV risk - aspirin and statin?</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span><span lang="EN-US">Review hypertension annually.</span></p>

<p class="MsoNormal"><span lang="EN-US"> </span></p>

<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" style="background:#CC99FF;border-collapse:collapse;border:none"><tr>
<td width="770" valign="top" style="width:462.1pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MsoNormal"><i><span lang="EN-US">In the UK Guidelines no longer
  recommend the use of Beta blockers as first line agents for hypertension (due
  to poorer efficacy and potential increase in risk of new-onset diabetes).
  Interestingly European guidelines do not distinguish Beta blockers from the
  other drugs stating they are all equally effective. Also the European guidelines
  also advocate pharmacological management for all patients with BP &gt;140/90!</span></i></p>
  </td>
 </tr></table>
<p class="MsoNormal"><span lang="EN-US"> </span></p>

<p class="MSBHeading1">Extra Notes:</p>

<p class="MSBHeading2">Types of Drugs</p>

<p class="MsoNormal"> </p>

<p class="MsoNormal">ALWAYS WARN PATIENT OF POTENTIAL SIDE-EFFECTS PRIOR TO
STARTING A NEW DRUG</p>

<p class="MsoNormal"> </p>

<ul style="margin-top:0cm" type="disc">
<li class="MsoNormal"><b>Thiazide diuretics</b></li>
</ul>
<p class="MsoNormal"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Eg Bendroflumethiazide  - 2.5mg OD</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>CI: gout</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>S/e: hypokalaemia, hyponatraemia, postural hypotension, impotence.</p>

<p class="MsoNormal" style="margin-left:21.0pt"><u><span style="text-decoration:
 none"> </span></u></p>

<p class="MsoNormal" style="margin-left:39.3pt;text-indent:-18.0pt"><span style="font-family:Symbol">·<span style='font:7.0pt "Times New Roman"'>     
</span></span><b>Calcium channel blockers</b></p>

<p class="MsoNormal"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Eg Amlodipine – 5-10mg OD</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span><span lang="PT-BR">S/e: flushes, oedema (ankle, face), gum hyperplasia,
fatigue</span></p>

<p class="MsoNormal"><span lang="PT-BR"> </span></p>

<ul style="margin-top:0cm" type="disc">
<li class="MsoNormal"><b><span lang="EN-US">ACE inhibitors</span></b></li>
</ul>
<p class="MsoNormal"><u><span lang="EN-US"><span style="text-decoration:none"> </span></span></u></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="EN-US">Eg  R</span><span lang="PT-BR">amipril – 10mg OD</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="EN-US">CI: bilatertal renal artery stenosis, aortic
valve stenosis</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="EN-US">s/e:  irritant cough, 1<sup>st</sup> dose
hypotension, hyperkalaemia, can precipitate RF, angioedema</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="EN-US">ACEi are paradoxically given in Chronic Renal
disease</span></p>

<p class="MsoNormal"><span lang="EN-US"> </span></p>

<ul style="margin-top:0cm" type="disc">
<li class="MsoNormal"><b><span lang="EN-US">Angiotensin II Receptor Antagonists
     (A2RBs)</span></b></li>
</ul>
<p class="MsoNormal" style="margin-left:36.0pt"><span lang="PT-BR"> </span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="EN-US">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="EN-US">Eg Losartan – 50mg OD </span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="EN-US">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="EN-US">Caution if valve disease or cardiomyopathy</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="EN-US">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="PT-BR">Monitor K</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span lang="EN-US">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="PT-BR">s/e: urticaria, vertigo, pruritis, hyperkalaemia</span></p>

<p class="MsoNormal"><b><span lang="PT-BR">                                              </span></b></p>

<ul style="margin-top:0cm" type="disc">
<li class="MsoNormal"><b><span lang="PT-BR">Direct Renin inhibitors</span></b></li>
</ul>
<p class="MsoNormal"><span lang="PT-BR"> </span></p>

<p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="PT-BR">Eg Aliskiren</span></p>

<p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="PT-BR">New drug, role uncertain</span></p>

<p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="PT-BR">s/e: diarrhoea, rash, hyperkalaemia (monitor K)</span></p>

<p class="MsoNormal"><span lang="PT-BR"> </span></p>

<ul style="margin-top:0cm" type="disc">
<li class="MsoNormal"><b><span lang="PT-BR">Beta blockers</span></b></li>
</ul>
<p class="MsoNormal"><span lang="PT-BR"> </span></p>

<p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="PT-BR">Eg Bisoprolol eg 2.5-5mg OD</span></p>

<p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="PT-BR">CI: asthma, acute HF </span></p>

<p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt"><span lang="PT-BR">-<span style='font:7.0pt "Times New Roman"'>       
</span></span><span lang="EN-US">s/e: bronchospasm, cold peripheries, fatigue,
impotence, HF.</span></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Very useful in patients who also have angina, AF or CHF</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Also consider in women of child bearing age; increased sympathetic
activity.</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>NB when withdrawing a Beta blocker step down dose gradually</p>

<p class="MsoNormal"> </p>

<p class="MSBHeading2">Types of Hypertension</p>

<p class="MsoNormal"> </p>

<p class="MSBsub-heading" style="margin-left:36.0pt;text-indent:-18.0pt"><u><span style="text-decoration:none">1)<span style='font:7.0pt "Times New Roman"'>    
</span></span></u>Primary Hypertension</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Aka Essential or idiopathic </p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>&gt;95% of cases</p>

<p class="MsoNormal"> </p>

<p class="MSBsub-heading" style="margin-left:36.0pt;text-indent:-18.0pt"><u><span style="text-decoration:none">2)<span style='font:7.0pt "Times New Roman"'>   
</span></span></u>Secondary Hypertension (&lt;5%)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Hypertension secondary to an identifiable cause</p>

<p class="MsoNormal" style="margin-left:21.0pt"> </p>

<p class="MSBemphasis1x"><u>Chronic Renal Disease</u></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>The most common secondary cause</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Any chronic kidney disease can lead to decreased excretion of Na <span style="font-family:Wingdings">à</span> fluid retention <span style="font-family:
Wingdings">à</span> increased intravascular volume <span style="font-family:
Wingdings">à</span> increased cardiac output (Frank-starling)</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Chronic renal disease is usu intrinsic:</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Primary glomerular disease eg Glomerulonephritis</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Secondary glomerular disease <b>–</b> eg Diabetes, SLE, RA,
systemic sclerosis,</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Also polycystic kidneys, chronic pyelonephritis</p>

<p class="MsoNormal"> </p>

<p class="MSBemphasis1x"><u>Renal Artery Stenosis</u></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Atherosclerosis <span style="font-family:Wingdings">à</span> decreased
blood flow to the kidney <span style="font-family:Wingdings">à</span> increase
renin <span style="font-family:Wingdings">à</span> RAA <span style="font-family:
Wingdings">à</span> vasoconstriction and fluid retention</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Can also lead to chronic renal failure</p>

<p class="MsoNormal"> </p>

<p class="MSBemphasis1x"><u>Endocrine disease</u></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Cushing’s (cortisol)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Glucocorticoid excess <span style="font-family:Wingdings">à</span>
increased vasoconstriction </p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>s/s: central obesity, striae, facial oedema and redness,
diabetes, bruising, muscle weakness, depression, oesteoporosis.</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Can be iatrogenic (long term steroid therapy, adrenal adenoma
(uncommon) or pituitary adenoma (&#8593;ACTH)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Diagnose by urinary cortisol (24 hour collection), dexamethasone
suppression test.</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Once diagnosed <span style="font-family:Wingdings">à</span>
investigate cause!</p>

<p class="MsoNormal" style="margin-left:57.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Conn’s syndrome (aldosterone)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Adrenal adenoma or carcinoma</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span><span style="font-family:Wingdings">à</span> primary hyperaldosteronism!</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>&#8593;Na+, &#8595;K+  - check U+Es in all patients with high
blood pressure</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Specifically exclude conn’s if: young (&lt;40), low K+, or
resistant HTN</p>

<p class="MsoNormal" style="margin-left:57.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Phaochromacytoma (catecholamines)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span><span class="MSBemphasis2xChar">TRIAD of EPISODIC</span> – <span class="MSBboldnormaltextChar">headache, sweating and palpitations</span></p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Also: labile or postural BP, pallor or diaphoresis (ie excessive
sweating)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>suspect in any patient with very variable BP</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>tumour of adrenal medulla <span style="font-family:Wingdings">à</span>
increased catecholamines</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>alpha-adrenoreceptors <span style="font-family:Wingdings">à</span>
vasoconstriction</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Beta-adrenoreceptors <span style="font-family:Wingdings">à</span>
tachycardia</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Diagnose by measuring urinary catecholamines (24 hour collection)</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Majority are benign</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>~15% are malignant <span style="font-family:Wingdings">à</span>
50% mortality!</p>

<p class="MsoNormal" style="margin-left:57.0pt"> </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Hyperthyroidism </p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>increased sympathetic drive</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Hyperparathyroidism</p>

<p class="MsoNormal" style="margin-left:57.0pt;text-indent:-18.0pt"><span style="font-family:Symbol;color:#7030A0">·<span style='font:7.0pt "Times New Roman"'>       
</span></span>Unknown cause</p>

<p class="MsoNormal"> </p>

<p class="MsoNormal"><u>Others</u>:</p>

<p class="MsoListParagraph" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
</span></span>Pregnancy, coarctation of the aorta, sleep apnoea, MAOI
antidepressants, OCP.</p>

<p class="MsoNormal"> </p>

<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" style="background:yellow;border-collapse:collapse;border:none"><tr>
<td width="770" valign="top" style="width:462.1pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MSBemphasis1x"><u>If ?Secondary cause</u></p>
  <p class="MsoNormal"> </p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span>U+Es</p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span>TFTs</p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span><b>24hr
  urine collection</b></p>
  <p class="MsoNormal" style="margin-left:103.65pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
  </span></span>Free cortisol (cushings)</p>
  <p class="MsoNormal" style="margin-left:103.65pt;text-indent:-18.0pt"><span style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>  
  </span></span>Catecholamines (phaochromocytoma)</p>
  <p class="MsoNormal" style="margin-left:67.65pt;text-indent:-18.0pt"><span style="font-family:Wingdings">è<span style='font:7.0pt "Times New Roman"'> </span></span>Renal
  Ultrasound artery doppler </p>
  <p class="MsoNormal"> </p>
  </td>
 </tr></table>
<p class="MsoNormal"> </p>

<p class="MSBemphasis1x"><u>Malignant Hypertension</u></p>

<p class="MsoNormal"><b> </b></p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Severe hypertension &gt;200/130</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>+ bilateral retinal haemorrhages </p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>+/- papilloedema</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Patient often has symptoms due to hypertension eg headache, visual
disturbance</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Can precipitate hypertensive emergencies – ARF, encephalopathy,
pulmonary oedema (require IV antihypertensives)</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>More common in younger patients</p>

<p class="MsoNormal" style="margin-left:21.0pt;text-indent:-18.0pt">-<span style='font:7.0pt "Times New Roman"'>       
</span>Look hard for underlying cause</p>

<p class="MsoNormal"> </p>

<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" style="background:#CC99FF;border-collapse:collapse;border:none"><tr>
<td width="770" valign="top" style="width:462.1pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MsoNormal"><u>Grading Hypertensive Retinopathy</u></p>
  <p class="MsoNormal"> </p>
  <p class="MsoNormal">I – silver or copper wiring – tortuous vessels with shiny
  walls</p>
  <p class="MsoNormal">II – AV nipping – narrowing where arteries cross veins)</p>
  <p class="MsoNormal">III - Flame haemorrhages and cotton wool spots</p>
  <p class="MsoNormal">IV - Papilloedema</p>
  <p class="MsoNormal"> </p>
  </td>
 </tr></table>
<p class="MsoNormal"> </p>

<p class="MsoNormal"><span style="font-size:12.0pt"> </span></p>

<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none"><tr>
<td width="770" valign="top" style="width:462.1pt;border:solid windowtext 1.0pt;
  background:#F2DBDB;padding:0cm 5.4pt 0cm 5.4pt">
  <p class="MSBHeading2">Guidelines and further Reading:</p>
  <p class="MsoNormal"><span style="font-size:12.0pt"> </span></p>
  <p class="MSBnormaltextCxSpFirst" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
  </span></span>NICE clinical Guideline 34. 2006. Hypertension: Management of
  Adults in Primary Care</p>
  <p class="MSBnormaltextCxSpMiddle" style="margin-left:21.0pt;text-indent:-18.0pt"><span style='font-family:"Times New Roman","serif"'>-<span style='font:7.0pt "Times New Roman"'>       
  </span></span>Oxford Handbook of clinical Medicine. 8<sup>th</sup> edition.
  2009. pp132-135</p>
  <p class="MSBnormaltextCxSpLast" style="margin-left:21.0pt;text-indent:0cm"> </p>
  </td>
 </tr></table>
<p class="MsoNormal"><span style="font-size:12.0pt"> </span></p>

<p class="MsoNormal"><i> </i></p>

<p class="MsoNormal"> </p>

</div>
				
				</div>
				<div id="sidebar" class="span-6 last">
					<p>Sidebar</p>
			  </div>
		  </div>
		</div>
			
		<div style="line-height:10px;">&nbsp;</div>
		<div id="footer" class="container">
				This is the 'sticky' footer
		</div>
	</body>
</html>